# Tribune Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tribune-therapeutics

- Industry: Biotechnology
- Headquarters: Stockholm, Sweden
- Website: www.tribunetx.com/
- Total disclosed funding: $25M
- Latest round: Series A (Mar 10, 2025)
- Investors on record: 7

## About

Based in Stockholm, Sweden, and founded in 2020, Tribune Therapeutics AB operates as a preclinical biopharmaceutical company. The company was founded by its CSO, Ole Kaasbøll. In May 2021, Tribune Therapeutics AB raised seed funding co-led by Novo Holdings, HealthCap, and Innovestor. As of 2024, the company is led by its CEO, Georg Vo Beiske. Tribune Therapeutics uses a pan-antifibrotic mechanism to develop a wide range of novel medicines to treat patients with fibrotic diseases. The company offers new medicines for fibrotic diseases, like liver fibrosis, kidney fibrosis, and lung fibrosis. The firm’s advanced candidate, TRX-44, is a protein therapeutic that targets CCN signaling. TRX-44 works by interfering with activated pro-fibrotic CCN domains, thereby blocking fibrotic signaling. This prevents the replacement of healthy tissue with scar tissue. In March 2025, Tribune Therapeutics AB raised an undisclosed amount of series A funding led by LifeArc, with participation from Industrifonden, Investinor, HealthCap, Innovestor, Inven2, and Novo Holdings. The company plans to utilize the March 2025 funding to prepare clinical trials for lead program and advance additional programs targeting protein family.

## Funding rounds

- Series A, Mar 10, 2025, $25M — HealthCap, Novo Holdings, Industrifonden, Investinor, Innovestor, LifeArc, Inven2
- Seed, May 1, 2021 — HealthCap, Novo Holdings, Innovestor, Inven2

## Investors

- HealthCap — Seed, Series A
- Novo Holdings — Seed, Series A
- Innovestor (https://capitalatlas.ai/funds/innovestor) — Seed, Series A
- Inven2 (https://capitalatlas.ai/funds/inven2) — Seed, Series A
- Industrifonden (https://capitalatlas.ai/funds/industrifonden) — Series A
- Investinor (https://capitalatlas.ai/funds/investinor) — Series A
- LifeArc (https://capitalatlas.ai/funds/lifearc) — Series A